Presentation is loading. Please wait.

Presentation is loading. Please wait.

Efficacy of Thiotepa-Busulfan-Cyclophosphamide (TBC) Conditioning and Autologous Transplantation As Consolidation for Systemic Non-Hodgkin Lymphoma with.

Similar presentations


Presentation on theme: "Efficacy of Thiotepa-Busulfan-Cyclophosphamide (TBC) Conditioning and Autologous Transplantation As Consolidation for Systemic Non-Hodgkin Lymphoma with."— Presentation transcript:

1 Efficacy of Thiotepa-Busulfan-Cyclophosphamide (TBC) Conditioning and Autologous Transplantation As Consolidation for Systemic Non-Hodgkin Lymphoma with Synchronous CNS Involvement  Andrew M. Brunner, MD, Eric Jacobsen, MD, Jennifer R. Brown, MD, PhD, David C. Fisher, Steven L. McAfee, MD, Robert J. Soiffer, MD, Philippe Armand, MD, PhD, Yi-Bin Chen, MD  Biology of Blood and Marrow Transplantation  Volume 22, Issue 3, Pages S120-S121 (March 2016) DOI: /j.bbmt Copyright © Terms and Conditions

2 Figure 1 Overall (top) and Progression-free (bottom) survival of patients with SCNSL following autologous cell transplantation with TBC conditioning. Biology of Blood and Marrow Transplantation  , S120-S121DOI: ( /j.bbmt ) Copyright © Terms and Conditions

3 Figure 2 Overall (top) and Progression-free (bottom) survival of patients with SCNSL according to number of treatment courses prior to autologous cell transplantation. Biology of Blood and Marrow Transplantation  , S120-S121DOI: ( /j.bbmt ) Copyright © Terms and Conditions


Download ppt "Efficacy of Thiotepa-Busulfan-Cyclophosphamide (TBC) Conditioning and Autologous Transplantation As Consolidation for Systemic Non-Hodgkin Lymphoma with."

Similar presentations


Ads by Google